Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-8,651
Closed -$210K 118
2025
Q2
$210K Sell
8,651
-10,688
-55% -$249K 0.14% 93
2025
Q1
$235K Buy
19,339
+9,999
+107% +$262K 0.16% 90
2024
Q4
$248K Buy
+9,340
New +$253K 0.17% 85
2024
Q1
Sell
-8,715
Closed -$251K 90
2023
Q4
$251K Sell
8,715
-1,000
-10% -$30.2K 0.25% 66
2023
Q3
$303K Sell
9,715
-720
-7% -$25.5K 0.34% 62
2023
Q2
$383K Sell
10,435
-5,930
-36% -$231K 0.39% 61
2023
Q1
$668K Sell
16,365
-18,525
-53% -$800K 0.72% 57
2022
Q4
$1.79M Sell
34,890
-100
-0.3% -$4.79K 1.8% 18
2022
Q3
$1.53M Sell
34,990
-350
-1% -$17K 1.7% 22
2022
Q2
$1.85M Sell
35,340
-1,335
-4% -$68K 1.87% 13
2022
Q1
$1.9M Sell
36,675
-2,302
-6% -$119K 1.72% 18
2021
Q4
$2.3M Buy
+38,977
New +$1.93M 2.12% 7

Other funds holding PFE

Insight Inv LLC's PFE Position: Q3 2025 in Review

Insight Inv LLC sold out of Pfizer (PFE) in Q3 2025, closing a stake of 8,651 shares — an estimated $210K sold.

Insight Inv LLC first reported a position in PFE in Q4 2021 and held it in 12 quarters. The position peaked at $2.3M in Q4 2021. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • Insight Inv LLC reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
  • Insight Inv LLC sold 8,651 Pfizer shares in Q3 2025, an estimated $210K.
  • Insight Inv LLC first reported a position in Pfizer in Q4 2021 and held it in 12 quarters.
  • Insight Inv LLC's Pfizer position peaked at $2.3M in Q4 2021.
  • 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on Insight Inv LLC's 13F filing for Q3 2025, filed 28 Oct 2025.